M. Giannella, B. Pinilla, J. A. Capdevila, J. Martínez Alarcón, P

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital 
Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
L. Boyanova  Clinical Microbiology and Infection 
Gut bacterial microbiota and obesity
I.J. Schalk  Clinical Microbiology and Infection 
Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients  M. Giannella, M. Alonso,
Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis  T. Steinmetz, N.
European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection.
Migrant health—a cause for concern?
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Virological tools to diagnose and monitor hepatitis C virus infection
Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital 
R. Cantón  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013  L.E.B. Nabarro, R.A. Lever, M. Armstrong,
F. Rodríguez-Gómez, O. Cuevas, J. Anguita, P. Muñoz 
Diagnosing infections—current and anticipated technologies for point-of-care diagnostics and home-based testing  L. Bissonnette, M.G. Bergeron  Clinical.
Impact of antibiotic restrictions: the pharmaceutical perspective
Vector control: a cornerstone in the malaria elimination campaign
Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non–severely ill patients 
E. Bouza, P. Muñoz, R. Alonso  Clinical Microbiology and Infection 
Training for the infectious diseases speciality in Norway
F. Grill, P. Muñoz, R. Jofre, E. Bouza 
G. Höffken  Clinical Microbiology and Infection 
Community-acquired pneumonia: the evolving challenge
Laboratory diagnosis and biosafety issues of biological warfare agents
B. Y. Lee, Z. S. Wettstein, S. M. McGlone, R. R. Bailey, C. A
Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective.
Levofloxacin in the treatment of ventilator-associated pneumonia
Metagenomics and probiotics
Previously unknown species of Aspergillus
Laboratory diagnosis of Clostridium difficile disease
The practice of travel medicine in Europe
T.M. File  Clinical Microbiology and Infection 
Sexually acquired Zika virus: a systematic review
Systematic review of antibiotic consumption in acute care hospitals
Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases  L. Romero, L. López,
F. Blasi, P. Palange, G. Rohde, T. Severin, G. Cornaglia, R. Finch 
Community-acquired pneumonia: epidemiologic and clinical consideration
Abstracts cont. Clinical Microbiology and Infection
Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial 
Training in infectious diseases and tropical medicine in Britain
Current experience in treating invasive zygomycosis with posaconazole
Vaccinations against respiratory tract infections at Hajj
Clinical infection services—the Leiden experience
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Listeriosis: a resurgent foodborne infection
Leishmaniasis in immunosuppressed individuals
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
F.J. Pastor, J. Guarro  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
Update on invasive aspergillosis: clinical and diagnostic aspects
Are we losing the fight against malaria one more time?
J.L. Balcázar  Clinical Microbiology and Infection 
Community-acquired acute bacterial meningitis in the elderly in Turkey
J.A. Pérez-Molina, F. Fernández  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
Rajko Saletinger, Mario Poljak, Franc Strle 
The future of diagnostic bacteriology
Presentation transcript:

Pneumonia treated in the internal medicine department: focus on healthcare-associated pneumonia  M. Giannella, B. Pinilla, J.A. Capdevila, J. Martínez Alarcón, P. Muñoz, J. López Álvarez, E. Bouza  Clinical Microbiology and Infection  Volume 18, Issue 8, Pages 786-794 (August 2012) DOI: 10.1111/j.1469-0691.2011.03757.x Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Study flow diagram. *Incident cases refer to patients newly diagnosed with pneumonia during the study weeks. Clinical Microbiology and Infection 2012 18, 786-794DOI: (10.1111/j.1469-0691.2011.03757.x) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions